Radiotherapy Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

Description

The Global Radiotherapy Market was valued at approximately USD 7 billion in 2023 and is projected to grow at a CAGR of 5.7% from 2024 to 2032. Radiotherapy employs high doses of radiation to eradicate cancer cells and reduce tumor size. The treatment, typically using X-rays, gamma rays, or charged particles, focuses on damaging the DNA of cancer cells, hindering their growth and division. Delivery methods include external machines like linear accelerators (external beam radiotherapy) or internal placement of radioactive materials close to cancer cells (brachytherapy).

Integration of advanced technologies, especially artificial intelligence (AI) and machine learning, is refining the precision and personalization of treatment plans. There is a pronounced shift towards precise tumor targeting, with techniques like image-guided radiotherapy (IGRT) and intensity-modulated radiotherapy (IMRT) minimizing harm to healthy tissues. Proton therapy is also increasingly preferred, particularly for pediatric cancers and tumors adjacent to critical structures, due to its precise dose distribution. Hypofractionated radiotherapy, delivering higher doses over fewer sessions, is further gaining popularity for its cost-effectiveness and convenience.

The overall industry is divided into type, application, end use , and region.

The market categorizes types into external beam radiation therapy, internal radiation therapy, and systemic radiation therapy. The external beam segment further divides into intensity-modulated radiation therapy, image-guided radiation therapy, proton therapy, and other methods. The external beam segment led the market, generating a revenue of USD 4.6 billion in 2023. Advancements in imaging and delivery systems have bolstered the precision and efficacy of external beam radiation therapy (EBRT) for enabling targeted tumor treatment while safeguarding surrounding healthy tissues.

Application-wise, the market covers lung, prostate, breast, cervical, head & neck cancers, among others. The breast cancer segment led with a valuation of USD 2 billion in 2023. Techniques like three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiation therapy (IMRT) have seen significant advancements for enhancing treatment precision, effectiveness, and patient outcomes.

Forecasts suggest that the North American radiotherapy market will hit USD 4.1 billion by 2032, with the U.S. leading at a revenue of USD 2.4 billion in 2023. North America robust healthcare infrastructure supports the adoption of cutting-edge medical technologies, such as proton therapy and advanced linear accelerators, ensuring patients receive precise and efficient treatments. Moreover, substantial investments in research and development from both public and private sectors are driving innovation in radiotherapy techniques and equipment, culminating in novel therapies and improved treatment outcomes.

Product Code: 3539

Chapter 1 Methodology and Scope

1.1 Market scope and definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates and calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advancement in radiotherapy
  - 3.2.1.2 Increasing number of cancer cases globally
  - 3.2.1.3 Growing public awareness related to cancer therapy
  - 3.2.1.4 Increasing healthcare infrastructure and R and D investments
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 Lack of skilled and experienced healthcare professionals in developing and underdeveloped regions
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Technological landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 External beam radiation therapy
- 5.2.1 Intensity-modulated radiation therapy (IMRT)
- 5.2.2 Image-guided radiation therapy (IGRT)
- 5.2.3 Proton therapy
- 5.2.4 Other external radiation therapies
5.3 Internal radiation therapy
5.4 Systemic radiation therapy

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Lung cancer
6.3 Prostate cancer
6.4 Breast cancer
6.5 Cervical cancer
6.6 Head and neck cancer
6.7 Other applications

Chapter 7 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Radiotherapy centers and ambulatory surgery centers
7.4 Cancer research institutes

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of Middle East and Africa

Chapter 9 Company Profiles

9.1 Accuray Incorporated
9.2 Brainlab AG
9.3 Curium
9.4 Canon Medical Systems Corporation
9.5 Elekta AB
9.6 Hitachi High-Tech Corporation
9.7 IBA Radiopharma Solutions
9.8 Isoray Inc.
9.9 Mevion Medical Systems
9.10 Mitsubishi Electric Corporation
9.11 Nordion, Inc.
9.12 NTP Radioisotopes SOC Ltd.
9.13 RefleXion
9.14 Toshiba Energy Systems and Solutions Corporation
9.15 Varian Medical Systems, Inc.